Inventor
WENYU ZHU
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes25%
C07KPeptides3%
PatentTitleYear
12,466,822Heterocyclic compounds as immunomodulators202512,378,243Quinoline compounds as inhibitors of KRAS202512,060,433CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy202412,030,884Pyrazoloquinoline KRAS inhibitors202412,030,883Hetero-tricyclic compounds as inhibitors of KRAS202411,999,740Fused pyrazine derivatives as A2A / A2B inhibitors202411,939,328Quinoline compounds as inhibitors of KRAS202411,851,442Tricyclic fused thiophene derivatives as JAK inhibitors202311,530,218Spiro compounds as inhibitors of KRAS202211,207,3021,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase202111,161,850Fused pyrazine derivatives as A2A / A2B inhibitors202111,161,855Tricyclic fused thiophene derivatives as JAK inhibitors2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to INCYTE CORP (12)· patent assignee history
2021–2023Patents assigned to INCYTE HOLDINGS CORP (3)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 12 | 2021–2025 |
| INCYTE HOLDINGS CORP | 3 | 2021–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2021–2025 |